FDA applicant
Cardiovascular Innovations
FDA records 1 decision for Cardiovascular Innovations (Dallas, TX) in 1998: 1 510(k) clearance. All are in product code DXT (Injector And Syringe, Angiographic). Its devices cite 2 predicates, 0 of them its own earlier devices. 2 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Cardiovascular Innovations’s devices, and how often a recall has named them.
FDA decisions per year
No FDA decision for Cardiovascular Innovations since 2007.
Recalls per year
1in 2021
Class I Class II/III not classified
Planning a device like Cardiovascular Innovations’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Cardiovascular”
FDA records each applicant name separately; these may or may not be the same firm.